Toshihiro Horii, Mitsuyoshi Yoshimoto, Akinori Kobayashi, Chihiro Kondo, Nobuaki Matsubara, Chikako Funasaka, Hiromichi Nakajima, Yasutoshi Kuboki, Kimiteru Ito, Masato Murakami, Shoko Ito, Tomoaki Higuchi, Naoki Kanazawa, Yuichi Funase, Daisuke Kano, Akira Inagaki, Saeko Mochinaga, Hikari Inagawa, Tatsushi Kobayashi, Anri Inaki. "First-in-human phase 0 safety, imaging, pharmacokinetics, and dosimetry study of
            <sup>64</sup>
            Cu-PD-32766, a carbonic anhydrase IX (CAIX)-targeting peptide, in patients with clear cell renal cell carcinoma (ccRCC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.tps605